Effects of ARC-hippocampus obestatin neural pathway on gastric motility and gastric emptying in diabetic rats

doi:10.12047/j.cjap.6034.2021.010

Abstract

Abstract: Objective: To investigate the obestatin neural projections from arcuate nucleus (ARC) to hippocampus in diabetic rats, and its effects on gastric motility and gastric emptying of rats. Methods: Diabetic model was established by fructose intake combined with streptozotocin injected intraperitoneally in healthy male Wistar rats. Diabetic rats were randomly divided into five groups: control group (NS group), 0.1, 1 and 10 pmol obestatin group, and obestatin + NBI27914 group, with 7 rats in each group. 0.5 μl saline (NS), obestatin (0.1 pmol, 1 pmol, 10 pmol) or the mixture (10 pmol obestatin + 60 pmol NBI27914) was injected into the hippocampus respectively, the gastric motility was recorded immediately after administration, and the gastric emptying was studied 15 min later. ARC-hippocampus obestatin neural pathway and ARC obestatin mRNA expression were compared between normal and diabetic rats with fluorogold (FG) retrograde tracing and immunofluorescence histochemical staining. Results: Compared with normal rats, the number of ARC FG/obestatin double labeled neurons and the expression level of ARC obestatin mRNA were decreased significantly in diabetic rats (P＜0.05); Obestatin could inhibit gastric motility and gastric emptying in a dose-dependent manner (P＜0.05~0.01) and the effects of obestatin could be partially blocked by NBI27914, an antagonist of corticotropin releasing factor receptor 1 (CRFR1) (P＜0.05). Compared with normal rats, the inhibitory effects of obestatin on gastric motility and gastric emptying were significantly decreased in diabetic rats (P＜0.05). Conclusion: There is an obestatin neural pathway between ARC and hippocampus, which participates in the regulation of gastric motility and gastric emptying in diabetic rats, and CRFR1 signal pathway is involved in this process. The damage of this neural pathway may participate in gastric motility dysfunction in early stage of diabetes.

Key words: obestatin, ARC-hippocampus obestatin neural pathway, gastric motility, diabetes, rat

CLC Number:

R363

GAO Hui-ying, ZHOU Yan, GAO Jie, LI Yan-jun, SUN Xiang-rong. Effects of ARC-hippocampus obestatin neural pathway on gastric motility and gastric emptying in diabetic rats[J]. CJAP, 2021, 37(3): 230-234.

References 16

[1]	Tao ZQ, Shi A, Zhao J. Epidemiologicalperspectives of diabetes[J]. Cell Biochem Biophys, 2015, 73(1): 181-185.
[2]	Guo FF, Gao SL, Xu L, et al. Arcuate nucleus orexin-A signaling alleviates cisplatin-induced nausea and vomiting through the paraventricular nucleus of the hypothalamus in rats[J]. Front Physiol, 2018, 9: 1811-1812.
[3]	Clarissa ML, Scott EK. Homeostatic and non-homeostatic controls of feeding behavior: Distinct vs. common neuralsystems[J]. Physiol Behav, 2018, 193(Pt B): 223-231.
[4]	Eman FK, Ghada AA. Obestatin protects and reverses nonalcoholic fatty liver disease and its associated insulin resistance in rats via inhibition of food intake, enhancing hepatic adiponectin signaling, and blocking ghrelin acylation[J]. Arch Physiol Biochem, 2019, 125(1): 64-78.
[5]	Slupecka DR, Grzesiak F, Kwiatkowski J, et al. The influence of enteral obestatin administration to suckling rats on intestinal contractility[J]. Gen Comp Endocrinol, 2017, 248: 69-78.
[6]	Mineko F, Koji A, Akihiro A, et al. Regulation of gastroduodenal motility: acyl ghrelin, des-acyl ghrelin and obestatin and hypothalamic peptides[J]. Digestion, 2012, 85(2): 90-94.
[7]	Uchida Y, Nagashima K, Yuri K. Fasting or systemic des-acyl ghrelin administration to rats facilitates thermoregulatory behavior in a cold environment[J]. Brain Res, 2018, 1696: 10-21.
[8]	Ando F,Gantulga GH, Nakata H, et al. Weaning stage hyperglycemia induces glucose-insensitivity in arcuate POMC neurons and hyperphagia in type 2 diabetic GK rats[J]. Neuropeptides, 2018, 68(2): 49-56.
[9]	Jessica CJ, Katy S, Alexander RG, et al. Anxiety cells in a hippocampal-hypothalamic circuit[J]. Neuron, 2018, 97(3): 670-683.
[10]	Débora S, Sandra DS, Ana LC. The role of ghrelin in regulating synaptic function and plasticity of feeding-associated circuits[J]. Front Cell Neurosci, 2019, 13(7): 205-211.
[11]	Ted MH, Joel DH, Vaibhav RK, et al. Hippocampus ghrelin signaling mediates appetite through lateral hypothalamic orexin pathways[J]. Elife, 2015, 4(5): pii: e11190- e11197.
[12]	Zhang JV, Ren PG, Orna AK, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake[J]. Science, 2005, 310(5750): 996-999..
[13]	Wang JY, Wang LH, Wei LZ, et al. Association of gastric emptying with ghrelin, obestatin and receptor (GHSR, GPR-39) in hypothalamus of diabetic rats[J]. Natl Med J China, 2010, 9016(16): 1137-1140.
[14]	Valeria PC, Helgi BS, Susana RD.Obestatin improves memory performance and causes anxiolytic effects in rats[J]. Biochem Biophys Res Commun, 2007, 352(4): 907-912.
[15]	Zhao YX, Shen ZX, Zhang DL, et al. Ghrelin ameliorates nerve growth factor dysmetabolism and inflammation in STZ-induced diabetic rats[J]. Metab Brain Dis, 2017, 32(3): 903-912.
[16]	Duygu U, Deniz B, Tuncay I, et al. Obestatin and ghrelin may have a complementary function during acute and chronic period in mice[J]. Protein Pept Lett, 2016, 23(4): 349-357.